NRP1 and neoplasm: In 2012, Benachour et al. developed a multifunctional CSNPs drug delivery system consisting of a gadolinium oxide core and silica shell functionalized with a chlorin based PS agent and a peptide for the active targeting of neuropilin-1 (NRP-1) overexpressed in tumor angiogenic vessels [47].